Patient Outcomes when Housestaff Exceed 80 Hours per Week
نویسندگان
چکیده
منابع مشابه
Hours per Patient Day: Not the Problem, Nor the Solution.
Hours per patient day (HPPD) is a metric that is easy to use in determining budgeted FTE and in comparing staffing across organizations. There are many considerations in determining the appropriate HPPD. The combination of automated patient acuity, staffing, and human resource systems provide a wealth of information for determining the budgeted HPPD and in making defensible requests for adjustm...
متن کاملJob Characteristics of Women Employed Less than 20 Hours per Week in the European Union
This paper aims at explaining to what extent women’s secondary part-time jobs have marginalized characteristics. Secondary part-time jobs are defined as jobs of less than 20 hours per week. Four clusters of job characteristics have been examined: characteristics related to wages and job security, the hours of work, working conditions, and workplace characteristics. Statistical analyses were car...
متن کاملWhich EPO dose per week?
Sir, Weiss et al. [1] have reported that once weekly erythropoietin b is as effective as more frequent dosing intervals in haemodialysis (HD) patients receiving treatment for the anaemia of end-stage renal failure. In view of their findings we switched all of our stable HD patients to once a week erythropoietin (EPO) providing that they were receiving less than 10 000 U subcutaneouslyuweek. A t...
متن کاملThe impact of the nursing hours per patient day (NHPPD) staffing method on patient outcomes: a retrospective analysis of patient and staffing data.
BACKGROUND In March 2002 the Australian Industrial Relations Commission ordered the introduction of a new staffing method - nursing hours per patient day (NHPPD) - for implementation in Western Australia public hospitals. This method used a "bottom up" approach to classify each hospital ward into one of seven categories using characteristics such as patient complexity, intervention levels, the ...
متن کامل7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.
Doxorubicin is a very effective antitumor agent, but its clinical use is limited by the occurrence of a cumulative dose-related cardiotoxicity, resulting in congestive heart failure. 7-Monohydroxyethylrutoside (monoHER), a flavonoid belonging to the semisynthetic hydroxyethylrutoside family, has been shown to protect against doxorubicin-induced cardiotoxicity when administered i.p. at a dose of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The American Journal of Medicine
سال: 2016
ISSN: 0002-9343
DOI: 10.1016/j.amjmed.2016.03.023